Please note: The information displayed on this page might be outdated.
Tricida, Inc.: Tricida is a late-stage pharmaceutical company focused on the development and commercialization of their drug candidate, TRC101, a non-absorbed polymer designed to treat metabolic acidosis by binding and removing acid from the gastrointestinal tract, or GI tract.
Healthcare/Drug Manufacturers
Based in...
North America
Public, USA
Market Cap
1B +
United States

Company Participants at Tricida Analyst & Investor Event

  • Jackie Cossmon, VP, Investor Relations and Communications

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Top 10 Holders of Tricida Inc

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
OrbiMed Advisors LLC 19.49 9,625,461 255.65 Stakes 2020-06-11
Wellington Management Co. LLP 7.60 3,752,020 99.65 13F 2020-03-31
T. Rowe Price Associates, Inc. (Investment Management) 7.07 3,490,263 92.70 13F 2020-03-31
Baker Bros. Advisors LP 5.40 2,666,015 70.81 13F 2020-03-31
The Vanguard Group, Inc. 4.79 2,367,431 62.88 Funds 2020-05-31
Vanguard Group, Inc. (Subfiler) 4.65 2,295,157 60.96 13F 2020-03-31
Redmile Group LLC 4.31 2,126,600 56.48 13F 2020-03-31
Avoro Capital Advisor LLC 2.76 1,365,000 36.25 13F 2020-03-31
BlackRock Fund Advisors 2.42 1,195,218 31.74 13F 2020-03-31
Farallon Capital Management LLC 2.02 1,000,000 26.56 13F 2020-03-31
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.